Why the study?
Does 32 x 0.5-MDCTA reliably exclude significant coronary stenoses in patients with complex and advanced CAD?
Does 32 x 0.5-MDCTA reliably exclude significant coronary stenoses in patients with complex and advanced CAD?
Answers are grounded in this paper and cite their sources.
32 x 0.5-MDCTA reliably excludes significant coronary stenoses in patients with advanced CAD, offering an alternative imaging modality for those with MRI contraindications like pacemakers.
MDCTA.Moreover, because heart rhythm and frequency control devices such as ICDs and permanent pacemakers are becoming increasingly more common in patients with advanced CAD and traditionally constitute an absolute contraindication to magnetic resonance imaging, 32 6 0.5-MDCTA emerges as an alternative to tomographic imaging of these patients with high temporal and spatial resolution, even though we have noticed limitations in the evaluation of the RCA in a few patients in this study. 17 We conclude that coronary 32 6 0.5-MDCTA reliably excludes > 50% and > 70% stenoses in vessels with a luminal diameter > 1.5 mm in a population with complex and advanced atherosclerotic disease regardless of calcification degree and territory location (left main, LAD, LCx, or RCA).Such results highlight the possibility of its present use in the follow up of patients with established chronic CAD, as well as, in the future, in the risk stratification of patients with chest pain and an intermediate likelihood of CAD.
No takes yet. Share an insight, caveat, or question.
Sülhattin Arslan (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: